Children's Mercy Hospital
Kansas City, Missouri, 64108, United States
NCT Number: NCT00224926
To explore carrier and infection status of T.tonsurans tinea capitis and characterize the host-pathogen interaction as it relates to the disease presentation. The general hypothesis for this study is as follows: the type of genotypic and phenotypic variant to which a child is exposed accounts for the presentation status observed in Trichophyton tonsurans infection.The global outcome of this investigation is to reveal potential new drug targets designed to improve treatment outcomes in these children.
Looking for future studies?
Notify Me2 year–5 year
All sexes
Observational
Kansas City, Missouri, 64108, United States
Tinea capitis is an overwhelmingly prevalent disease of childhood estimated to be present in approximately 1 in 20 children at any point in time with an equal number of children serving as carriers of the fungal pathogen. Despite the widespread nature of the disease, the natural course of the infection remains incompletely described. The study will be driven by the following hypothesis: the type of genotypic and phenotypic variant to which a child is exposed accounts for the presentation status observed in Trichophyton tonsurans infection.
A fungal scalp culture will be acquired from all participants using a brush culture technique. Samples will be collected once a month over a two year time period.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
sterile, soft-head toothbrush massaged on scalp
Children's Mercy Hospital Kansas City
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07043582
Bacterial Infections and Mycoses, Dermatomycoses
Istanbul, Kadıköy, Turkey (Türkiye)
View Trial DetailsNCT07068256
Bacterial Infections and Mycoses, Dermatomycoses
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT00645242
Bacterial Infections and Mycoses, Dermatomycoses
Montgomery, Alabama, United States
View Trial DetailsNCT04144491
Bacterial Infections and Mycoses, Common Cold
Kabwohe, Sheema, Uganda
View Trial Details